Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Retatrutide for Sale > High Purity Retatrutide Synthetic Peptide Lyophilized Powder For Laboratory Research
High Purity Retatrutide Synthetic Peptide Lyophilized Powder For Laboratory Research buy - large image1
High Purity Retatrutide Synthetic Peptide Lyophilized Powder For Laboratory Research buy - image1
High Purity Retatrutide Synthetic Peptide Lyophilized Powder For Laboratory Research buy - image2
High Purity Retatrutide Synthetic Peptide Lyophilized Powder For Laboratory Research buy - image3
High Purity Retatrutide Synthetic Peptide Lyophilized Powder For Laboratory Research buy - image4
High Purity Retatrutide Synthetic Peptide Lyophilized Powder For Laboratory Research buy - image5
High Purity Retatrutide Synthetic Peptide Lyophilized Powder For Laboratory Research buy - image6

High Purity Retatrutide Synthetic Peptide Lyophilized Powder For Laboratory Research

TDS 7380 Inquiries

Unit Price:

$32/MT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

CHINA

Brand:

any

Packaging:

5-60mg/vials

Sample Available:

Yes

Price valid (until):

2027-10-19

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
45 days
Qualification:
Main Products:

Semag lutide,Tirzepatide,Retatrutide,raw material,GHK-CU,TB500(Thymosin B4 AceTate)

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    This compound lyophilized laboratory reagent is synthesized via solid‑phase peptide synthesis under strict aseptic and standardized manufacturing conditions. Through multi‑step coupling synthesis, desalting treatment and vacuum freeze‑drying procedures, homogeneous fine dry solid powder is obtained. The finished reagent exhibits no caking, discoloration, sticky aggregation or visible foreign particulate contaminants. Multi‑stage reversed‑phase chromatographic purification is implemented to eliminate truncated peptide fragments, coupling reagent residues and salt‑related impurities. HPLC detection verifies each synthetic component reaches no less than 99% purity, providing stable and reproducible experimental data for cell‑level assays, molecular interaction exploration and laboratory model research.
    Packaged in individual crimp‑sealed glass vials, this reagent supports flexible procurement selections and multi‑vial assembled kits, satisfying various research workflows ranging from preliminary screening trials to large‑scale laboratory validation projects.
    The complete manufacturing procedure complies with standardized internal quality‑control specifications, covering raw material confirmation, component ratio adjustment, impurity elimination, desalting process and low‑temperature sterile lyophilization. Every production batch undergoes comprehensive physical and chemical detection prior to shipment. COA documents, HPLC spectrograms, mass‑spectrometry identification reports and batch inspection records can be provided for laboratory file archiving and experimental validation work.
    Important Research Statement: This product is exclusively intended for scientific laboratory research use only. It shall not be adopted for human‑relevant trials, clinical evaluation, medical diagnosis or consumer‑oriented applications. Any utilization beyond laboratory research scope is forbidden.
    The lyophilized reagent is susceptible to temperature variation, moisture and air exposure. For long‑term preservation, store unopened vials tightly sealed at ‑20℃ within dry, dark and low‑humidity surroundings. Avoid repeated freeze‑thaw cycles, high‑temperature exposure and intense direct light irradiation which may damage molecular structure. Once the seal is opened, prepare working solution without delay to lower moisture absorption and external contamination risks.
    Global bulk order logistics service is accessible. Custom labeling and packaging solutions are available upon request. Each vial is equipped with premium butyl rubber stopper together with aluminum crimp cap to keep internal anhydrous status. Shock‑absorbing inserts, waterproof barrier bags and reinforced cartons are applied for outer‑package to mitigate risks of mechanical damage, powder leakage and moisture deterioration during transit.

    Product Specifications & Technical Parameters

    Product Name: Synthetic Peptide

    Chemical Form: Lyophilized Freeze‑dried Powder

    Appearance: Fine off‑white or white dry powder

    Purity: ≥99% (HPLC tested for each batch)

    Sequence Confirmation: Validated by Mass Spectrometry

    Standard Specification: Single vial package; multi‑vial assembled kits

    Solubility: Readily dissolves in sterile water and weak aqueous solution

    Moisture Residue: Maintained at low residual level

    Storage Condition: Sealed storage at ‑20℃, dry and light‑shielded environment

    Transport Condition: Cold‑chain protected shipment

    Packaging Format: Independent sterile glass vial, vacuum crimp‑sealed

    Supply Option: In‑stock supply, bulk wholesale, customized labeling & packaging

    Quality Control & Core Advantages

    Precisely assembled synthetic peptide components. Mass‑spectrometry testing confirms molecular integrity, well‑suited for molecular‑interaction‑based laboratory investigation. Multi‑level purification and desalting workflow. Sequential chromatographic purification combined with desalting treatment efficiently removes synthetic by‑products, organic residuals and redundant salt substances that interfere with cell and lab model experiments. Reliable batch‑to‑batch consistency. Fixed synthesis formula, component proportion, purification and lyophilization parameters are applied for every production batch. Minor deviations in appearance, solubility and structural indicators are acceptable for continuous research projects and repeated laboratory tests. Complete batch testing documentation. Each lot is attached with HPLC purity report, MS verification data and full COA document set, convenient for lab record keeping and institutional audit inspection. Diverse ordering alternatives. Bulk multi‑vial kits are supported to fit different experimental consumption requirements.

    FAQ

    Q1: What documents can you provide together with the goods?

    A1: We can supply full set of batch documents including COA, HPLC spectrogram and mass spectrometry identification report for each lot, which can be used for laboratory filing and internal audit.
    Q2: What storage requirements should be followed for this lyophilized peptide reagent?

    A2: Unopened vials need to be tightly sealed and kept at ‑20℃ under dry, dark and low‑humidity conditions. Repeated freeze‑thaw cycles and strong light exposure should be avoided. After opening the vial, prepare working solution promptly.
    Q3: What transport mode will be adopted for bulk orders?

    A3: Cold‑chain protected shipment is applied. Outer packaging uses shock‑absorbing inserts, waterproof barrier bags and reinforced cartons to reduce damage risk during international transit.
    Q4: Can you support custom labeling and special packaging demands?

    A4: Yes, customized labeling and packaging services are available based on customer requirements for bulk wholesale orders.
    Q5: How about batch consistency of your synthetic peptide products?

    A5: Each production batch follows fixed synthesis, purification and lyophilization parameters. Strict physical and chemical inspection is implemented before delivery to guarantee stable batch‑to‑batch performance for repeated laboratory experiments.
    Q6: Which solvent is recommended to prepare working solution for this peptide powder?

    A6: Sterile water or weak aqueous solution is recommended for dissolution, which can obtain good dissolving effect for the lyophilized powder.
    Items Specifications
    Product name Retatrutide
    Purity ≥99% (HPLC)
    Appearance White Lyophilized Powder
    Shop Epitalon Lyophilized Peptide CAS 307297-39-8 Bulk Raw Material Supply-Detailed Image 1
    Shop Epitalon Lyophilized Peptide CAS 307297-39-8 Bulk Raw Material Supply-Detailed Image 2
    Shop Epitalon Lyophilized Peptide CAS 307297-39-8 Bulk Raw Material Supply-Detailed Image 3
    Shop Epitalon Lyophilized Peptide CAS 307297-39-8 Bulk Raw Material Supply-Detailed Image 4
    Shop Epitalon Lyophilized Peptide CAS 307297-39-8 Bulk Raw Material Supply-Detailed Image 8
    Shop Epitalon Lyophilized Peptide CAS 307297-39-8 Bulk Raw Material Supply-Detailed Image 9
    Shop Epitalon Lyophilized Peptide CAS 307297-39-8 Bulk Raw Material Supply-Detailed Image 10
    Shop Epitalon Lyophilized Peptide CAS 307297-39-8 Bulk Raw Material Supply-Detailed Image 12
    Shop High Purity Raw Laboratory Reagent Lyophilized Powder Premium SLU-PP-322 White Compound Material-Detailed Image 9
    Shop High Purity Raw Laboratory Reagent Lyophilized Powder Premium SLU-PP-322 White Compound Material-Detailed Image 10
    Shop High Purity Raw Laboratory Reagent Lyophilized Powder Premium SLU-PP-322 White Compound Material-Detailed Image 11
    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Certificates
    • High Purity Retatrutide Synthetic Peptide Lyophilized Powder For Laboratory Research Certificates 1 TDS

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Polypeptide

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Semag lutide,Tirzepatide,Retatrutide,raw material,GHK-CU,TB500(Thymosin B4 AceTate)

    Location:

    Room 1002-C3973, No. 80, Yongtai Modaonan Street, Yongping Subdistrict, Baiyun District, Guangzhou City

    Payment Terms:

    TT against copy of documents,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    45 days

    Year of Establishment:

    2026

    Anymang is a US-based trading company dedicated to the global supply and formulation of high-quality cosmetic raw materials, with a core focus on peptide ingredients. Committed to bridging premium suppliers and beauty manufacturers worldwide, we deliver pure, stable, and efficacious peptides—including anti-aging, brightening, and firming peptides—alongside a full spectrum of cosmetic actives and custom formulation solutions. With rigorous quality control and compliance with US safety standards, we ensure consistent batch quality and reliable delivery. Our experienced team provides professional technical support and tailored services to help clients develop competitive skincare and personal care products. Trusted by partners across the globe, Anymang stands as your dependable partner for innovative, high-performance cosmetic raw materials and peptide formulations.

  • Inquiry History
    7380 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Australia

    GMP Grade 99% Retatrutide Lyophilized Powder CAS 2381089-83-2

    10 G Jun 12, 2026
    Palestine

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    10 MG Mar 16, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.